Side-by-side comparison of AI visibility scores, market position, and capabilities
L'Oréal outperformed the global beauty market with €44B in 2025 sales and acquired Kering Beauté for ~€4B, accelerating into luxury fragrance and aesthetics.
L'Oréal S.A. was founded in 1909 by chemist Eugène Schueller in Paris and has grown into the world's largest beauty company, headquartered in Clichy, France, and listed on Euronext Paris. For fiscal year 2025, L'Oréal reported sales of €44.05 billion, up 4% like-for-like, outperforming an improving global beauty market, with gross margin rising to 74.3% and operating margin at 20.2%. The company operates across four divisions — Consumer Products (mass market), L'Oréal Luxe (prestige), Professional Products (salons), and Dermatological Beauty (dermo-cosmetics) — with a portfolio of 37 international brands including L'Oréal Paris, Lancôme, Maybelline, Kérastase, La Roche-Posay, and CeraVe.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.